ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.90
-0.22%
Dow Jones
40,724.41
1.27%
Gold vs US Dollar
2,463.99
1.72%
Brent Oil
83.405
-1.11%
Bitcoin
64,964.08
0.18%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Atreca Inc (BCEL)

  7. Atreca Inc (BCEL) News

Atreca (BCEL)

Atreca Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCEL
DateTimeSourceHeadlineSymbolCompany
11/03/202420:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCELAtreca Inc
11/03/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
06/02/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
05/01/202421:57Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:BCELAtreca Inc
26/12/202313:39Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCELAtreca Inc
26/12/202313:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
26/12/202313:30GlobeNewswire Inc.Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to ImmunomeNASDAQ:BCELAtreca Inc
14/11/202321:30GlobeNewswire Inc.Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic AlternativesNASDAQ:BCELAtreca Inc
28/09/202300:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
21/09/202313:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
21/09/202313:00GlobeNewswire Inc.Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb CrossNASDAQ:BCELAtreca Inc
14/09/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
18/08/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCELAtreca Inc
16/08/202322:20Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BCELAtreca Inc
10/08/202321:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCELAtreca Inc
10/08/202321:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCELAtreca Inc
10/08/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
10/08/202321:05GlobeNewswire Inc.Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate RestructuringNASDAQ:BCELAtreca Inc
04/08/202323:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
04/08/202323:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
19/07/202314:18Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCELAtreca Inc
15/06/202323:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
15/06/202323:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
15/06/202323:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
15/06/202323:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
15/06/202323:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
15/06/202323:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
15/06/202323:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
15/06/202321:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCELAtreca Inc
05/06/202313:00GlobeNewswire Inc.Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual MeetingNASDAQ:BCELAtreca Inc
 Showing the most relevant articles for your search:NASDAQ:BCEL

Your Recent History

LSE
IEBC
Ishrc Euro
USOTC
PSTRQ
PostRock Energy (CE)
NASDAQ
CTRN
Citi Trends
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved